This study is an open-label, randomized, multicenter trial that incorporates a multi-arm design comparing each of 3 non-TNFi (Tumor Necrosis Factor inhibitor) medications to a second TNFi (active control) within a sequential multiple assignment…
- Investigator
- Melissa E Elder
- Ages
- 2 Years - 17 Years
- Sexes
- All